---
title: "Pomalidomide - Multiple Myeloma"
sidebar: mydoc_sidebar
permalink: db08910-mesh-d009101-1.html
toc: false 
---


Path ID: `DB08910_MESH_D009101_1`
{% include image.html url="images/db08910-mesh-d009101-1.png" file="db08910-mesh-d009101-1.png" alt="db08910-mesh-d009101-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:C467566">MESH:C467566 </a> | Pomalidomide | Drug |
| <a href="https://identifiers.org/CL:0000623">CL:0000623 </a> | Natural killer cell | Cell |
| <a href="https://identifiers.org/GO:0002423">GO:0002423 </a> | Natural killer cell mediated immune response to tumor cell | BiologicalProcess |
| <a href="https://identifiers.org/UniProt:P35354">UniProt:P35354 </a> | Prostaglandin G/H synthase 2 | Protein |
| <a href="https://identifiers.org/MESH:D011453">MESH:D011453 </a> | Prostaglandins | ChemicalSubstance |
| <a href="https://identifiers.org/GO:0006954">GO:0006954 </a> | Inflammatory response | BiologicalProcess |
| <a href="https://identifiers.org/UniProt:P01375">UniProt:P01375 </a> | Tumor necrosis factor | Protein |
| <a href="https://identifiers.org/reactome:R-HSA-75893">reactome:R-HSA-75893 </a> | TNF signaling | Pathway |
| <a href="https://identifiers.org/CL:0000092">CL:0000092 </a> | Osteoclast | Cell |
| <a href="https://identifiers.org/GO:0045453">GO:0045453 </a> | Bone resorption | BiologicalProcess |
| <a href="https://identifiers.org/GO:0010573">GO:0010573 </a> | Vascular endothelial growth factor production | BiologicalProcess |
| <a href="https://identifiers.org/GO:0001525">GO:0001525 </a> | Angiogenesis | BiologicalProcess |
| <a href="https://identifiers.org/InterPro:IPR001321">InterPro:IPR001321 </a> | Hypoxia-inducible factor-1 alpha | GeneFamily |
| <a href="https://identifiers.org/MESH:D009101">MESH:D009101 </a> | Multiple myeloma | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Pomalidomide | POSITIVELY REGULATES | Natural Killer Cell |
| Natural Killer Cell | POSITIVELY REGULATES | Natural Killer Cell Mediated Immune Response To Tumor Cell |
| Natural Killer Cell Mediated Immune Response To Tumor Cell | NEGATIVELY CORRELATED WITH | Multiple Myeloma |
| Pomalidomide | DECREASES ACTIVITY OF | Prostaglandin G/H Synthase 2 |
| Prostaglandin G/H Synthase 2 | INCREASES ABUNDANCE OF | Prostaglandins |
| Prostaglandins | POSITIVELY REGULATES | Inflammatory Response |
| Inflammatory Response | POSITIVELY CORRELATED WITH | Multiple Myeloma |
| Pomalidomide | DECREASES ACTIVITY OF | Tumor Necrosis Factor |
| Tumor Necrosis Factor | PARTICIPATES IN | Tnf Signaling |
| Tnf Signaling | POSITIVELY REGULATES | Inflammatory Response |
| Pomalidomide | NEGATIVELY REGULATES | Osteoclast |
| Osteoclast | POSITIVELY REGULATES | Bone Resorption |
| Bone Resorption | OCCURS IN | Multiple Myeloma |
| Pomalidomide | NEGATIVELY REGULATES | Vascular Endothelial Growth Factor Production |
| Vascular Endothelial Growth Factor Production | POSITIVELY REGULATES | Angiogenesis |
| Pomalidomide | NEGATIVELY REGULATES | Hypoxia-Inducible Factor-1 Alpha |
| Hypoxia-Inducible Factor-1 Alpha | POSITIVELY REGULATES | Angiogenesis |
| Angiogenesis | POSITIVELY CORRELATED WITH | Multiple Myeloma |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB08910](https://go.drugbank.com/drugs/DB08910)
  - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789204/](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789204/)
